The Influence of NPPA/NPPB Haplotype on Natriuretic Peptide Plasma Levels
- Conditions
- AnesthesiaSurgical Procedure, Operative
- Registration Number
- NCT04327258
- Lead Sponsor
- Insel Gruppe AG, University Hospital Bern
- Brief Summary
Crosssectional study to analyse the genetic influence on levels of cardiac biomarkers (BNP, NT-proBNP).
- Detailed Description
Background
Natriuretic peptides play an important role in risk stratification and management of patients undergoing non-cardiac surgery. However, due to genetic variability, the levels of these biomarkers may differ in individual patients with cardiac derangement. In the preoperative setting, genetic contribution to natriuretic peptide plasma level variability has not yet been determined.
Objective
The aim of this study is to assess genetic contribution to NP plasma level variability in a Swiss cohort.
Methods
Cross-sectional association study in a cohort of non-cardiac surgery patients.
This study is a Subproject of a prospective cohort study registered under the ID 041/09.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 437
- 18 years and older
- Written informed consent
- Scheduled surgery
Exclusion Criteria
- No informed consent
- Cognitive impairment
Not provided
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Influence of NPPA/NPPB haplotype on natriuretic peptide plasma levels Blood samples collected at start of anesthetic procedure Estimation of genetic effects on natriuretic peptide (BNP, NT-proBNP) plasma levels
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Department of Anaesthesiology and Pain Medicine, Inselspital, University of Bern
🇨ðŸ‡Bern, Switzerland